Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 31 sec ago

Envisia Therapeutics Secures $16.5 Million In Additional Series A Financing

Wed, 03/23/2016 - 16:26
Additional Financing to Support Advancement of Programs in Glaucoma, Diabetic Macular Edema and Age-related Macular Degeneration RESEARCH TRIANGLE PARK, N.C., March 23, 2016 -- (Healthcare Sales & Marketing Network) -- Envisia Therapeutics, a clinical...
Biopharmaceuticals, Ophthalmology, Venture Capital
Envisia Therapeutics, ENV515, glaucoma

Roche Submits Filing to FDA For cobas(R) Procalcitonin (Pct) Assay to Help Clinicians Assess Response of Septic Patients to Treatment

Wed, 03/23/2016 - 16:20
INDIANAPOLIS, March 23, 2016 -- (Healthcare Sales & Marketing Network) -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it has submitted the Elecsys BRAHMS PCT (Procalcitonin) assay for Premarket Notification (510k) to the U.S. Food and Drug Administr...
Biopharmaceuticals, FDA
Roche Group, cobas, Procalcitonin, sepsis

EarlySense Targets Growth in Southeast Asia with New Distributor

Wed, 03/23/2016 - 16:16
Partnership with MyHealth Sentinel Strengthens EarlySense's Global Reach RAMAT GAN, Israel, March 23, 2016 -- (Healthcare Sales & Marketing Network) -- EarlySense, the market leader in contact-free monitoring solutions, today announced it has signed a ...
Devices, Monitoring, Distribution
EarlySense, myHealth Sentinel

Apotex Launches First Generic Version of Merck's Nasonex(R)

Tue, 03/22/2016 - 17:21
TORONTO, March 22, 2016 -- (Healthcare Sales & Marketing Network) - Apotex Inc. announced today that it has launched the first generic version of Merck's Nasonex® nasal spray (mometasone furoate monohydrate) in the United States. Apotex's mometas...
Biopharmaceuticals, Generics, Product Launch
Apotex, Nasonex, mometasone furoate, Merck

Aerin Medical, Developer of Non-invasive Treatments for Nasal Breathing Disorders, Announces $16.7 million Series C Financing

Tue, 03/22/2016 - 17:19
SUNNYVALE, Calif., March 22, 2016 -- (Healthcare Sales & Marketing Network) -- Aerin Medical, Inc., a privately held medical device company, announced the closing of a $16.7 million Series C financing round. Aerin's Series C financing was completed in two...
Devices, Venture Capital, Personnel
Aerin Medical

First FDA-Approved Medicine Manufactured Using 3D Printing Technology Now Available

Tue, 03/22/2016 - 17:12
SPRITAM® is Designed to Transform Experience of Taking Epilepsy Medication BLUE ASH, Ohio, March 22, 2016 -- (Healthcare Sales & Marketing Network) -- Aprecia Pharmaceuticals today announced that SPRITAM® (levetiracetam) tablets, for oral suspe...
Biopharmaceuticals, Drug Delivery, Neurology, Product Launch
Aprecia Pharmaceuticals, SPRITAM, levetiracetam, epilepsy

Boston Scientific Launches the AXIOS(TM) Stent and Electrocautery Enhanced Delivery System

Tue, 03/22/2016 - 17:08
MARLBOROUGH, Mass., March 22, 2016 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) today announced the launch of the AXIOS™ Stent and Electrocautery Enhanced Delivery System to help physicians manage two serious complicati...
Devices, Interventional, Product Launch
Boston Scientific, AXIOS Stent, pancreatic pseudocyst

Varian Launches New Smaller Calypso Beacon Transponder To Guide Radiation Therapy In Soft Tissue Tumors

Tue, 03/22/2016 - 14:04
New transponder receives FDA 510(K) clearance and CE Mark PALO ALTO, Calif., March 22, 2016 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (VAR) today announced a new Calypso® 17G soft tissue Beacon® transponder that is 50 ...
Devices, Oncology, FDA, Regulatory, Product Launch
Varian Medical Systems, Calypso, Beacon transponder, radiotherapy, radiosurgery

Nihon Kohden Debuts Breakthrough in Neuromonitoring Remote Access with Live View Panel

Tue, 03/22/2016 - 13:53
Intuitive, Customizable System Enables Real-time Multi-Patient Management from Centralized Location IRVINE, Calif.--(Healthcare Sales & Marketing Network)--Nihon Kohden, a U.S.-market leader in medical instrumentation solutions, has commercially launche...
Devices, Monitoring, Neurology, Product Launch
Nihon Kohden, Live View Panel, electroencephalography, polysomnogaphy

Acutus Medical Completes $75 Million Series C Financing

Tue, 03/22/2016 - 13:37
Expands Existing Blue Chip Syndicate with Institutional and Strategic Investors Financing Will Support Quest to Transform EP Market by Expanding Clinical Studies and Upcoming European and U.S. Launches of AcQMap™ High Resolution Imaging and Mapping Syst...
Devices, Cardiology, Venture Capital
Acutus Medical, AcQMap, dipole density, atrial fibrillation

The Netherlands' Radiotherapy Group is Country's First to Use Elekta's Esteya Electronic Brachytherapy to Treat Skin Cancer Patients

Tue, 03/22/2016 - 13:26
EDE, Netherlands, March 22, 2016 -- (Healthcare Sales & Marketing Network) -- On March 3, Radiotherapy Group clinicians at Ziekenhuis Gelderse Vallei (Ede, the Netherlands) used their Esteya® electronic brachytherapy system for the first time to treat...
Devices, Oncology
Elekta, Esteya, brachytherapy, radiotherapy

Juniper Pharmaceuticals Affirms Development Pathway for Oxybutynin Intra-vaginal Ring for Overactive Bladder in Women

Mon, 03/21/2016 - 15:07
JNP-0101 on Track for 2016 Investigational New Drug ("IND") Filing BOSTON, March 21, 2016 -- (Healthcare Sales & Marketing Network) -- Juniper Pharmaceuticals, Inc. (JNP) ("Juniper" or the "Company"), a women's health ther...
Biopharmaceuticals, Urology, Drug Delivery, FDA
Juniper Pharmaceuticals, oxybutynin, intra-vaginal, overactive bladder

B. Braun and ICU Medical Sign Expanded Long-Term International Distribution Agreement

Mon, 03/21/2016 - 15:03
Agreement calls for B. Braun's distribution of ICU Medical's SwabCap product line to be first phase of the collaboration between the two companies to bring innovative patient safety products to the infusion therapy market worldwide SAN CLEMENTE, Calif.,...
Devices, Distribution
ICU Medical, B. Braun, SwabCap

Threshold Pharmaceuticals Appoints Stew Kroll as Chief Operating Officer

Mon, 03/21/2016 - 13:57
SOUTH SAN FRANCISCO, Calif., March 21, 2016 -- (Healthcare Sales & Marketing Network) -- Threshold Pharmaceuticals, Inc. (THLD), a clinical-stage biopharmaceutical company developing novel therapies for cancer, announced the appointment of Stewart M. Kroll...
Biopharmaceuticals, Oncology, Personnel
Threshold Pharmaceuticals

Tokai Strengthens Development Team Through the Addition of Kelly Lindert, M.D., as Executive Vice President and Head of Development

Mon, 03/21/2016 - 13:52
BOSTON--(Healthcare Sales & Marketing Network)--Tokai Pharmaceuticals Inc. (TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced that it ...
Biopharmaceuticals, Oncology, Personnel
Tokai Pharmaceuticals, prostate cancer, galeterone

FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis

Mon, 03/21/2016 - 13:48
Test speeds treatment decisions, contributes to better patient care INDIANAPOLIS, March 21, 2016 -- (Healthcare Sales & Marketing Network) -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received approval from the U.S. Food and Drug A...
Diagnostics, FDA
Roche Group, Roche Diagnostics, hepatitis C, COBAS AmpliPrep

LEO Pharma Receives Scientific Approval of Enstilar(R) for the Treatment of Psoriasis in EU

Mon, 03/21/2016 - 13:39
The marketing approval of Enstilar® would make it the first fixed combination topical foam treatment for people living with psoriasis vulgaris in the EU. BALLERUP, Denmark, March 18, 2016 -- (Healthcare Sales & Marketing Network) -- LEO Pharma toda...
Biopharmaceuticals, Dermatology, Regulatory
LEO Pharma, Enstilar, psoriasis

Amgen And UCB Announce Positive Top-Line Results From Phase 3 Study Evaluating Romosozumab In Men With Osteoporosis

Mon, 03/21/2016 - 13:21
BRIDGE Study Met Primary and All Secondary Endpoints Results Add to Growing Body of Positive Late-Stage Data Evaluating Efficacy and Safety of Romosozumab in Patients With Osteoporosis THOUSAND OAKS, Calif., and BRUSSELS, March 20, 2016 -- (Healthcar...
Amgen, Romosozumab, Osteoporosis

The Myriad myRisk(R) Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer

Fri, 03/18/2016 - 16:57
New Data Presented at the Society for Gynecologic Oncology Annual Meeting SALT LAKE CITY, March 18, 2016 -- (Healthcare Sales & Marketing Network) -- Myriad Genetics, Inc. (MYGN), a leader in molecular diagnostics and personalized medicine, today announ...
Diagnostics, Oncology, Personalized Medicine
Myriad Genetics, myRisk, Hereditary Cancer, endometrial cancer, myChoice HRD

ProNAi Therapeutics Appoints Jeffrey H. Cooper and Tran Nguyen to its Board of Directors

Fri, 03/18/2016 - 13:57
Company opens San Francisco area office VANCOUVER, March 18, 2016 -- (Healthcare Sales & Marketing Network) - ProNAi Therapeutics, Inc. (DNAI), a clinical-stage oncology company advancing novel therapeutics for patients with cancer and hematological di...
Biopharmaceuticals, Oncology, Personnel
ProNAi Therapeutics

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong